. Author manuscript; available in PMC: 2018 Oct 1.

Published in final edited form as: Clin Cancer Res. 2017 Jun 21;23(19):5912–5922. doi: 10.1158/1078-0432.CCR-17-0284

Table 1.

Characteristics of patients with invasive epithelial ovarian/tubal/peritoneal cancer by ROCA/CA125 status, histotype and TP53 autoantibody positivity in the UKCTOCS study. *TP53 AAb (+): TP53 autoantibody screen positive; N/A: Not available

ROCA/CA125 (+) N= 164			ROCA/CA125 (-) N = 56

Histology		TP53 AAb (+)* No. (%)	Histology		TP53 AAb (+)* No. (%)

Type	No.		Type	No.
Serous	119	27 (22.7%)	Serous	28	6(21.4%)
Mucinous	1	0 (0.0%)	Mucinous	1	1 (100.0%)
Endometrioid	19	2 (10.5%)	Endometrioid	6	0 (0.0%)
Clear cell	7	0 (0.0%)	Clear cell	7	1 (14.3%)
Poorly differentiated	17	4 (23.5%)	Poorly differentiated	11	0 (0.0%)
Mixed	1	1 (100.0%)	N/A	3	1 (33.3%)
Total	164	34 (20.7%)	Total	56	9(16.1%)